Walleye Capital
TMCI icon

Walleye Capital’s Treace Medical Concepts TMCI Stock Holding History

Walleye Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,990
Closed -$543K – 5125
2024
Q4 		$543K Buy
72,990
+60,020
+463% +$402K ﹤0.01% 2913
2024
Q3 		$75.2K Buy
+12,970
New +$83.3K ﹤0.01% 4515
2023
Q4 		– Sell
-139,839
Closed -$1.83M – 5514
2023
Q3 		$1.83M Buy
139,839
+88,239
+171% +$1.62M ﹤0.01% 1805
2023
Q2 		$1.32M Sell
51,600
-3,269
-6% -$84.4K ﹤0.01% 1622
2023
Q1 		$1.38M Buy
+54,869
New +$1.29M 0.02% 936
2021
Q3 		– Sell
-10,914
Closed -$341 – 1811
2021
Q2 		$341 Buy
+10,914
New +$347K 0.01% 892

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's TMCI Position: Q1 2025 in Review

Walleye Capital sold out of Treace Medical Concepts (TMCI) in Q1 2025, closing a stake of 72,990 shares — an estimated $543K sold.

Walleye Capital first reported a position in TMCI in Q2 2021 and held it in 6 quarters. The position peaked at $1.83M in Q3 2023. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

  • Walleye Capital reported no remaining Treace Medical Concepts position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 72,990 Treace Medical Concepts shares in Q1 2025, an estimated $543K.
  • Walleye Capital first reported a position in Treace Medical Concepts in Q2 2021 and held it in 6 quarters.
  • Walleye Capital's Treace Medical Concepts position peaked at $1.83M in Q3 2023.
  • 138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.